Determinants and progression of stigma in amyotrophic lateral sclerosis/motor neuron disease
No Thumbnail Available
Authors
Young, Carolyn
Chaouch, Amina
McDermott, Christopher
Al-Chalabi, Ammar
Chhetri, Suresh Kumar
Bidder, Caroline
Edmonds, Eric
Ellis, Cathy
Annadale, Joe
Wilde, Lisa
Check for full-text access
Issue Date
01/05/2025
Type
Journal article
Language
Keywords
Mental Health
Alternative Title
Abstract
Objective: Stigma in amyotrophic lateral sclerosis/motor neurone disease (ALS/MND) may be felt or enacted; felt stigma covers feeling devalued by the illness, whereas enacted stigma refers to being treated differently because of it. Stigma in ALS/MND has been shown to increase social withdrawal, worsen quality of life, and reduce use of assistive devices, so we explored prevalence and factors influencing stigma.
Methods: Participants in the Trajectories of Outcome in Neurological Conditions-ALS study completed scales measuring stigma, fatigue, spasticity, functioning, mood, worry, self-esteem, and perceived health, as well as demographic information and symptoms like head drop or emotional lability. Following transformation to interval-scale estimates, data were analyzed by regression, structural equation modeling, and trajectory models.
Results: Stigma was experienced by 83.5% of 1059 respondents. Worry, disease severity (King's stage ≥ 3), emotional lability, fatigue, spasticity, and bulbar onset increase stigma. In contrast, increasing age, living with spouse/partner, and greater self-esteem were associated with reduced stigma. Trajectory analysis over 30 months (N</i> = 1049) showed three groups, the largest (70.2%) had high levels of stigma which significantly increased during follow-up. In a recently diagnosed subset of 347 participants, stigma was experienced early in the disease course (7 months after diagnosis), and for 77.2% stigma significantly increased over time.
Conclusions: Both felt and enacted stigma are frequently perceived by people living with ALS/MND. Younger people and those with bulbar onset, emotional lability, worry, fatigue, and spasticity, or at more advanced clinical stages, are at greater risk.
Description
Citation
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3–4), 192–202. https://doi.org/10.1080/21678421.2024.2435969
Publisher
License
Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume
26
Issue
Issue 3-4